主页 > 医学讨论 >

一个新的检测食管腺癌的生物标记物

A novel biomarker for the detection of esophageal adenocarcinoma

J Thorac Cardiovasc Surg 2007;133:82-87

Zane T. Hammoud, MDa,*, Sunil Badve, MDb, Romil Saxena, MDb, Kenneth A. Kesler, MDa, Karen Rieger, MDa, Linda H. Malkas, PhDc, Robert J. Hickey, PhDc

OBJECTIVES: Proliferating cell nuclear antigen is a component of the DNA synthesome and functions in DNA replication and repair. Our group has recently identified an acidic isoform of proliferating cell nuclear antigen, cancer-specific proliferating cell nuclear antigen, that appears to be present only in malignant tissue. We sought to determine the presence of cancer-specific proliferating cell nuclear antigen in esophageal dysplasias and invasive adenocarcinomas to assess its potential utility in discriminating malignancy.
METHODS: With a polyclonal antibody to cancer-specific proliferating cell nuclear antigen, immunohistochemical staining was performed on samples from a total of 30 patients with Barrett esophagus with varying degrees of dysplasia and 18 patients with invasive adenocarcinoma. We also performed cancer-specific proliferating cell nuclear antigen immunohistochemical staining on a commercially available tissue microarray and on specimens obtained from endoscopic biopsies. As controls, immunohistochemical staining for cancer-specific proliferating cell nuclear antigen was performed on normal esophageal tissue and immunohistochemical staining for proliferating cell nuclear antigen was performed on all specimens with a commercially available antibody.
RESULTS: Of the Barrett esophagus specimen, 14 showed no dysplasia, 8 showed low-grade dysplasia, and 8 showed high-grade dysplasia. None of these specimens stained positively for cancer-specific proliferating cell nuclear antigen. Of the 18 adenocarcinoma specimens, all stained positively for cancer-specific proliferating cell nuclear antigen. There was no significant cancer-specific proliferating cell nuclear antigen expression in normal esophageal tissue, and proliferating cell nuclear antigen expression was noted to a high degree in all tissues.
CONCLUSIONS: Cancer-specific proliferating cell nuclear antigen appears to demonstrate high specificity for esophageal adenocarcinoma. This marker therefore may prove useful in differentiating invasive cancer from high-grade dysplasia. Cancer-specific proliferating cell nuclear antigen also holds future promise as a biomarker for esophageal adenocarcinoma.
http://jtcs.ctsnetjournals.org/cgi/content/abstract/133/1/82 希望战友们给予关注。 [标签:content1][标签:content2]

阅读本文的人还阅读:

『转载』中科院上海药物

【medical-news】心脏衰竭诊

【bio-news】生物物理所与

【每日动态】每日生物医

【每日动态】2011年度药

作者:admin@医学,生命科学    2011-02-16 05:16
医学,生命科学网